Foundation Medicine enters clinical cancer genomics collaboration with Celgene
Release Date: 2011-05-19
Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, announced a strategic collaboration with Celgene Corporation. The collaboration – Foundation Medicine’s second major pharmaceutical company alliance in 2011 – is focused on using Foundation Medicine’s comprehensive clinical cancer genomics test in ongoing trials of Celgene drug candidates.| Type: | NORMAL |
| Url: | http://www.pharmabiz.com/NewsDetails.aspx?aid=62966&sid=2 |